Aquestive Therapeutics (AQST) Cash from Investing Activities Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 13.93% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 57.14% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 551.55% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -3,664.79% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -3.45% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -22,919.16% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 140.78% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 52.90% |
| 10 | Aquestive Therapeutics | 487.99 Mn | 377.25 Mn | 10.98 Mn | 61.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.48% |
| Dec 31, 2025 | -466.67% |
| Sep 30, 2025 | -193.75% |
| Jun 30, 2025 | -205.71% |
| Mar 31, 2025 | -365.52% |
| Dec 31, 2024 | 6.25% |
| Sep 30, 2024 | 47.02% |
| Jun 30, 2024 | 95.76% |
| Mar 31, 2024 | -1,350.00% |
| Dec 31, 2023 | 38.46% |
| Sep 30, 2023 | 91.21% |
| Jun 30, 2023 | -22.01% |
| Mar 31, 2023 | 98.08% |
| Dec 31, 2022 | 95.12% |
| Sep 30, 2022 | -1,968.67% |
| Jun 30, 2022 | -248.97% |
| Mar 31, 2022 | -0.97% |
| Dec 31, 2021 | -125.85% |
| Sep 30, 2021 | -118.42% |
| Jun 30, 2021 | -73.21% |